News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mirna Therapeutics, Inc. Presents Updates on Development Program for Lead Therapeutic Candidate


5/22/2012 11:23:04 AM

AUSTIN, Texas--(BUSINESS WIRE)-- Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA replacement therapies for cancer, announced that new preclinical data from its lead therapeutic program will be presented this week at two different conferences: 2012 TIDES Oligonucleotide and Peptide Research, Technology, and Product Development Conference in Las Vegas, Nevada, and the 2012 European Microsymposium on Small RNAs in Basel, Switzerland.

Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES